CRSP AI forecast — CRISPR Therapeutics AG - Common Shares

Hedgewing's neural-network ensemble rates CRSP a Buy as of . 1-day forecast: $41.83 (+4.00%). Last close $40.19 (+0.10%).

5-day and 20-day price targets, model confidence, and the full AI analysis are available with a free account.